05/06/2026
https://www.facebook.com/share/1DtHZumF1h/?mibextid=wwXIfr
Ask your practitioner at Live Well
About this new multi pronged tool
For Metabolic Health
In stock now 🙌🙌🙌🙌
Managing metabolic dysfunction requires more than focusing on glucose alone.
Eriomin®️ is a patented lemon flavonoid, targeting the interconnected drivers of metabolic dysregulation: hyperglycaemia, inflammation, and oxidative stress.
Emerging evidence from human RDBPCTs in prediabetic populations shows Eriomin®️ can:
• Support healthy blood glucose regulation
• Improve insulin sensitivity
• Reduce inflammatory markers (hs-CRP, IL-6, TNF-α)
• Decrease oxidative stress
Notably, these outcomes occurred without changes to diet or body weight, highlighting a metabolic mechanism of action rather than a caloric effect.
A key differentiator?
Eriomin®️ has been shown to increase endogenous GLP-1 levels, supporting:
🍋 Insulin secretion
🍋 Glucose uptake
🍋 Glycaemic control
For practitioners addressing insulin resistance, prediabetes, and metabolic syndrome, this offers a targeted, evidence-informed approach.
Practitioners, explore the full clinical insights in our technical paper, Addressing glycaemic dysregulation and adiposity via gastrointestinal GLP-1, inflammatory, and oxidative pathways.
